Informations générales (source: ClinicalTrials.gov)
Lyon Sarcoid Uveitis Cohort (LUCS)
Observational
Hospices Civils de Lyon (Voir sur ClinicalTrials)
janvier 2016
janvier 2025
29 juin 2024
Sarcoidosis is a systemic disease with unknown etiology. Chronicity of the disease is
observed in 1/3 of cases. Five percent of the affected patients are expected to die due
to pulmonary worsening. After pulmonary complications, ocular complications are one of
the most frequent complications. In hospital setting 2 to 15% of patients who come for
initial uveitis diagnosis are after examination due to Sarcoidosis. Sarcoidosis diagnosis
is based on paraclinical exams (biological, radiography) and histological confirmation.
Corticotherapy (local or general) is usually used to cure sarcoid uveitis. In case of
failure immunosuppressor or anti-tumor necrosis factor (TNF) can be used. In 10% of cases
ocular symptoms including blindness are observed. Only treatment administrated quickly
after diagnosis of sarcoid uveitis can prevent from ophthalmologic complications.
The main objective of the Lyon Sarcoid Uveitis Cohort study is to analyze the relevance
of the paraclinical exam for sarcoid uveitis diagnosis, and to define a better visual and
extra-ophthalmologic prognosis and describe the therapeutic practice in our Department.
This study is proposed to all patients diagnosed with Sarcoid uveitis with a histological
confirmation and referred to the internal medicine department of the Croix-Rousse
hospital, Lyon, France, for etiologic diagnosis or treatment.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Hospices Civils de Lyon - Lyon - France | Pascal SEVE | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Diagnosis of sarcoid uveitis
- First consultation in the department of Internal Medicine at the Croix-Rousse
hospital, Lyon, France
- Diagnosis of sarcoid uveitis
- First consultation in the department of Internal Medicine at the Croix-Rousse
hospital, Lyon, France
- None